Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.628, 2011-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
NZ Pharmac saves, but says no to imatinib mesylate
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 374, 2002-01 ,pp. :
Pharmac announces new funding decisions
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 618, 2010-01 ,pp. :
Pharmac funds type 2 DM drug, sets 3-year funding path
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 461, 2004-01 ,pp. :
Pharmac doing a good job in New Zealand?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 248, 2000-01 ,pp. :
NZ imposes new subsidy restrictions for anticonvulsants
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :